The University of Kentucky Markey Cancer Center has treated the first patient in US with a new immunotherapy for lung cancer. UK Markey Cancer Center becomes the first site in the country…
Tag: Treatment Options For Lung Cancer
Role of Personalized Treatment for Lung Cancer Patients
Lung cancer is one of the most deadly disease and is responsible for many deaths each year. There are two major types of lung cancer: small cell and non-small cell lung cancer….
Lurbinectedin Combination gets FDA Approval for Extensive-Stage SCLC
The U.S. Food and Drug Administration (FDA) has approved lurbinectedin (Zepzelca) in combination with atezolizumab or and hyaluronidase-tqjs for adults with extensive-stage small cell lung cancer (ES-SCLC) without disease progression after frontline…
FDA Grants Breakthrough Therapy to Olomorasib to Treat Lung Cancer
Eli Lilly and Company has announced that US Food and Drug Administration (FDA) has granted breakthrough therapy designation to olomorasib, in combination with anti-PD1 therapy Keytruda for first-line treatment of patients with…
Tarlatamab Shows Improved Overall Survival Over Chemotherapy in SCLC
Tarlatamab received accelerated approval for treatment of patients with previously treated small-cell lung cancer. It meaningfully improved overall survival compared with Chemotherapy in SCLC patients that progressed on or after initial platinum-based…
FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC
The FDA has granted accelerated approval to Telisotuzumab vedotin for the treatment of patients with locally advanced or metastatic, nonsquamous non-small cell lung cancer with high c-MET protein overexpression. This approval is…
Heart-Sparing Technique in Lung Cancer Radiotherapy
A new study has been presented at ESTRO 2025 introducing RAPID-RT study. It utilizes an innovative rapid-learning approach to evaluate the impact of treatment modifications in radiotherapy. It offers a more inclusive…
Metformin Appears To Fight Lung Cancer But Only In Overweight Patients
Metformin is a common drug prescribed for patients with Type 2 patients to lower their blood sugar. It is a FDA approved drug since 1995 and is used by about 20 million…